CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,122 Cr | ₹2,802 Cr | ₹2,517 Cr | ₹2,405 Cr | ₹1,547 Cr |
What is the latest Consolidated Net Profit of CIPLA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹4,122 Cr |
Mar2023 | ₹2,802 Cr |
Mar2022 | ₹2,517 Cr |
Mar2021 | ₹2,405 Cr |
Mar2020 | ₹1,547 Cr |
How is Consolidated Net Profit of CIPLA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹4,122 Cr | 47.10 | |
Mar2023 | ₹2,802 Cr | 11.33 | |
Mar2022 | ₹2,517 Cr | 4.65 | |
Mar2021 | ₹2,405 Cr | 55.50 | |
Mar2020 | ₹1,547 Cr | - |
Compare Consolidated Net Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹120,602.9 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
MANKIND PHARMA | ₹103,515.0 Cr | 0.6% | 3.1% | 34.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.5% |
0.1% |
19.9% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses